Zydus Cadila gets US Food and Drug Administration nod for diabetes medication

On October 31, 2020, Zydus had filed a new drug application (NDA) with the USFDA seeking approval to market Sitagliptin base 25, 50 and 100 mg tablets.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news